Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
2/11/2026
Shiling Pharma Targets 2028 for Nasal Spray Version of Wegovy Obesity ...
2/11/2026
China Eyes Approval for Russian Cancer Vaccine 'Enteromix'
2/11/2026
GSK's RSV Vaccine Arexvy Moves Forward in China
2/11/2026
NHSA Issues Trial Measures for Early Communication on Reference Drugs
2/10/2026
AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
2/10/2026
Weekly China Regulatory Roundup: EGFR, TROP2 Approvals and Broad IND A...
2/10/2026
Insilico and CMS Partner on AI-Driven CNS and Autoimmune Drug Programs
2/10/2026
Hengrui and Kailera Advance Obesity Therapy After Encouraging Mid-Stag...
2/10/2026
Cascade Raises $72M to Advance MASH, Obesity and Diabetes Pipeline
2/10/2026
3D Medicines Advances Envafolimab Toward Full Market Approval in China
2/9/2026
CDE Issues Technical Guideline for Generic Sodium Iodide [131I] Oral S...
2/9/2026
J&J Wins China Approval Expanding Subcutaneous Daratumumab Use
2/9/2026
InnoCare Wins China IND Clearance for VAV1 Molecular Glue Degrader ICP...
2/9/2026
BioKangtai Cancels Planned Vaccine Joint Venture With AstraZeneca in C...
2/9/2026
Roche and Henlius–Organon Resolve U.S. Patent Dispute Over Pertuzumab...
2/9/2026
Ascletis Begins U.S. Phase II Trial of Oral GLP-1R Agonist ASC30 for T...
2/9/2026
GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...
2/9/2026
Lilly Expands China Partnership With Innovent in New Global Oncology a...
2/7/2026
Recent Executive Moves
2/7/2026
Delonix Secures IND Clearance for Novel MenB Vaccine DX-104 in China ...
2/7/2026
Bio‑Thera and Avalon Forge 15‑Year Deal to Bring Keytruda Biosimilar...
2/7/2026
China Moves to Accelerate New Healthcare Insurance Models and Large‑S...
2/6/2026
Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
2/6/2026
Genturn Life Raises CNY Tens of Millions in Angel Round to Advance Re...
2/6/2026
Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...
2/6/2026
DCH Auriga Teams Up with Hengrui to Expand Innovative Medicines in HK ...
2/6/2026
Everest Medicines Gains Chinese Approval for VELSIPITY® in UC
2/6/2026
China Launches Nationwide Crackdown on BMI Fraud in Mental Health Sect...
2/5/2026
Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
2/5/2026
Fosun Secures Priority Review in China for Luvometinib's New Indicatio...
Page:
1
/
61
Total number of articles:
1811
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit